Trial intelligence / Profile preview

Trimebutine Maleate for Gastric Visualization in Acute Upper GI Bleeding

NCT07749300Phase 3Not yet recruiting

Sponsor
Assiut University
Start
Sep 2026
Primary completion
Sep 2027
01

Overview

A Phase 3 trial of trimebutine in acute upper gastrointestinal bleeding (UGIB), sponsored by Assiut University. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

trimebutine
03

Conditions

acute upper gastrointestinal bleeding (UGIB)

Beyond the preview

Go deeper on NCT07749300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07749300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call